Back
Aurinia Pharmaceuticals Stock Price Chart

Sold-out (twice) tech raise for accredited investors only
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite
Sell
46
AUPH
Aurinia Pharmaceuticals
Last Price:
$7.97
Seasonality Move:
-9.99%
7 Day Trial
ALL ACCESS PASS
$
7

From 50,000 investors to Nasdaq? Mode's next move...
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUPH is experiencing slight selling pressure.
Aurinia Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.12 | Sell |
20-day SMA: | 8.1 | Sell |
50-day SMA: | 8.04 | Sell |
200-day SMA: | 7.86 | Sell |
8-day EMA: | 8.04 | Sell |
20-day EMA: | 8.07 | Sell |
50-day EMA: | 8.06 | Sell |
200-day EMA: | 7.8 | Buy |
Aurinia Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 42.87 | Sell |
Chaikin Money Flow: | -390411 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.97 - 8.25) | Sell |
Bollinger Bands (100): | (7.76 - 8.3) | Sell |
Aurinia Pharmaceuticals Technical Analysis
May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Aurinia Pharmaceuticals Stock
Is Aurinia Pharmaceuticals Stock a Buy?
-
Aurinia Pharmaceuticals share price is 7.84 while AUPH 8-day simple moving average is 8.12, which is a Sell signal.
-
The stock price of AUPH is 7.84 while Aurinia Pharmaceuticals 20-day SMA is 8.10, which makes it a Sell.
-
Aurinia Pharmaceuticals 50-day simple moving average is 8.04 while AUPH share price is 7.84, making it a Sell technically.
-
AUPH stock price is 7.84 and Aurinia Pharmaceuticals 200-day simple moving average is 7.86, creating a Sell signal.
AUPH Technical Analysis vs Fundamental Analysis
Sell
46
Aurinia Pharmaceuticals (AUPH)
is a Sell
Is Aurinia Pharmaceuticals a Buy or a Sell?
-
Aurinia Pharmaceuticals stock is rated a SellThe current Aurinia Pharmaceuticals [AUPH] share price is $7.84. The Score for AUPH is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Aurinia Pharmaceuticals Stock Info
Market Cap:
1.1B
Price in USD:
7.84
Share Volume:
1.4M
Aurinia Pharmaceuticals 52-Week Range
52-Week High:
10.67
52-Week Low:
5.15
Sell
46
Aurinia Pharmaceuticals (AUPH)
is a Sell
Aurinia Pharmaceuticals Share Price Forecast
-
What is the Aurinia Pharmaceuticals stock price today?The Aurinia Pharmaceuticals stock price is 7.84 USD today.
-
Will AUPH stock go up or go down?Aurinia Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Aurinia Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aurinia Pharmaceuticals is overvalued.
Is Aurinia Pharmaceuticals Stock a Buy?
-
Aurinia Pharmaceuticals share price is 7.84 while AUPH 8-day exponential moving average is 8.04, which is a Sell signal.
-
The stock price of AUPH is 7.84 while Aurinia Pharmaceuticals 20-day EMA is 8.07, which makes it a Sell.
-
Aurinia Pharmaceuticals 50-day exponential moving average is 8.06 while AUPH share price is 7.84, making it a Sell technically.
-
AUPH stock price is 7.84 and Aurinia Pharmaceuticals 200-day simple moving average is 7.80, creating a Buy signal.
Fundamental Analysis of Aurinia Pharmaceuticals
Is Aurinia Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.56 per share, and an increase next year of $0.17 per share.
Technical Analysis of Aurinia Pharmaceuticals
Should I short Aurinia Pharmaceuticals stock?
-
AUPH Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Aurinia Pharmaceuticals is a Sell
-
Aurinia Pharmaceuticals Relative Strength Index (RSI) is 42.87, which suggest Aurinia Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Aurinia Pharmaceuticals is (7.97 - 8.25), which suggest Aurinia Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Aurinia Pharmaceuticals is (7.76 - 8.3), which suggest Aurinia Pharmaceuticals is a Sell
* Aurinia Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.